CONNECT WITH US
HealthTech

HealthTech

An mRNA booster for cellular immunotherapy shows potential against aggressive brain tumors

Medical Xpress logo

Published on

Add as a preferred source on Google
An mRNA booster for cellular immunotherapy shows potential against aggressive brain tumors

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

A team led by researchers at the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim (UMM) has developed a new approach to more effectively direct immune cells against glioblastomas. In experimental models, they were able to show that a targeted mRNA vaccine significantly increases the potency of therapeutic immune cells. The paper is published in the journal Cancer Research.

The vaccine not only ensures that the cancer-fighting T cells proliferate rapidly, but it also facilitates their entry into the brain, where they can attack the tumors. The results open up new avenues for the development of more effective immunotherapies against this aggressive form of cancer.

Glioblastomas are considered the most aggressive form of brain cancer. Despite surgery, radiation and chemotherapy, the tumors often recur. High hopes are therefore pinned on immunotherapies that specifically activate the body's own immune cells to attack cancer cells. However, such treatments have so far reached their limits, particularly when it comes to brain tumors: Too few of the therapeutic immune cells reach the tumor—and once there, they often lose their activity.

A research team led by Lukas Bunse (head of the Neuro-Oncology Section at UMM and a scientist at the DKFZ) and Michael Platten (director of the University Clinic for Neurology at UMM and head of department at the DKFZ) has now investigated how these obstacles can be overcome.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.